Author: VBS

Written by: Brian K. Do, MD September 2019 Guymer RH, Wu Z, Hodgson LA, et al. Subthreshold Nanosecond Laser Intervention in Age-Related Macular Degeneration: The LEAD Randomized Controlled Clinical Trial. Ophthalmology. 2019 Jun;126(6):829-838. doi: 10.1016/j.ophtha.2018.09.015. Epub 2018 Sep 20. Rosenfeld PJ, Feuer WJ. Warning: Do not Treat Intermediate AMD with Laser Therapy. Ophthalmology. 2019 Jun;126(6):839-840. doi: 10.1016/j.ophtha.2018.12.016. […]

Written by: Joshua D. Levinson, MD September 2019 Campochiaro PA, Marcus DM, Awh CC, et al. The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial. Ophthalmology. 2019 Aug;126(8):1141-1154 Intravitreal anti-vascular endothelial growth factor (VEGF) therapy has revolutionized the treatment of neovascular age-related macular degeneration […]

Written by: Christopher Aderman, MD August 2019 Robyn H. Guymer, MBBS, PhD, Caroline M. Markey, PhD, Ian L. McAllister, MBBS, PhD, Mark C. Gillies, MBBS, PhD, Alex P. Hunyor, MBBS, Jennifer J. Arnold, MBBS, on behalf of the FLUID Investigators. Ophthalmology. Volume 126, Number 5, May 2019 Analysis of the CATT, VIEW, and HARBOR studies […]

Written by: Brian K. Do, MD August 2019 Yang J, Zhang Q, Motulsky EH, Thulliez M, Shi Y, Lyu C, de Sisternes L, Durbin MK, Feuer W, Wang RK, Gregori G, Rosenfeld PJ. Two-Year Risk of Exudation in Eyes with Non-Exudative AMD and Subclinical Neovascularization Detected with Swept Source OCT Angiography. American Journal of Ophthalmology […]

Written by: Katherine E. Talcott, MD Rajesh B, Zarranz-Ventura J, Fung AT et al. Safety of 6000 intravitreal dexamethasone implants. Br J Ophthalmol. 2019 April 30. [Epub ahead of print] Corticosteroids, including the intravitreal dexamethasone implant, are used to treat macular edema from multiple etiologies. Clinical trials have revealed an increase in IOP and cataract […]

Written by: Prethy Rao, MD Zhu X, Shen P, Li C, Li H, Huang H, Shi K, Wang L, Zhang X, Lu L. Retina. 2019 Jul;39(7):1305-1311 Myopic macular foveoschisis in patients is often a daunting clinical finding in many practices as progression and surgical outcomes are often variable. While present in 15-20% of myopic patients, […]

Written by: Katherine E. Talcott, MD Lindtjorn B, Krohn J Austeng D et al. Nonsupine positioning after macular hole surgery: a prospective multicenter study. Ophthalmol Retina. 2019 May;3(5):388-92. Macular hole (MH) surgical repair typically involves the release of tangential traction on the retina by lifting the hyaloid, removal of the internal limiting membrane, epiretinal membrane, […]

Written by: Prethy Rao, MD Falavarjani K.G., Hadi Y., Habibi A., Anvari P., Modarres M., Parvaresh M.M.,Jafari S. & Alemzadeh S.A. Ophthalmol Retina. 2019 Jun;3(6):538-539 We live in an exciting time in retina with new pathway drugs being rolled into clinical trials and markets—from TIE2 receptors, DARPins, smaller VEGF antibody fragments (conbercerpt, brolicizumab) etc—for both macular […]